What are the available payment terms?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

What is the lead time for orders?

The average lead time is one month for both peak and off-peak seasons.

Superb Poultry Vaccine Avian Pox Live Quail-Adapted Strain with GMP Standard

Name: Superb Poultry Vaccine Avian Pox Live Quail-Adapted Strain with GMP Standard
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1987192062

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$5.00-10.00

2,000 Sets

Product profile

Customization

Available

Varieties

General Disease Prevention Medicine

Component

Vaccines

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Transport Package

Carton

Trademark

Moosun

Origin

China

HS Code

3004909090

Production Capacity

50000pieces /Month

Key features

Live Quail-Adapted Strain: Effective live vaccine specifically adapted for quail strain to prevent Avian Pox.

GMP Standard Production: Manufactured under Good Manufacturing Practice standards ensuring high quality.

Flexible Packaging Sizes: Available in 10 bottles per box with 20, 30, 40, or 60 boxes per carton.

OEM and ODM Services: Custom branding and manufacturing services available for partners.

Comprehensive R&D Team: Supported by 20 dedicated R&D engineers for product development.

Global Market Reach: Exports to North America, Europe, Asia, Africa, and other international markets.

Manufacturer Direct Supply: Direct supply from a manufacturer with 360 employees and large plant area.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤11.01h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.

Product Q&A

Q:What is the immune period for this vaccine?

The immune period is 5 months for adult chickens and 2 months for newborn chicks.

Q:How should the vaccine be administered?

Administer by subcutaneous thorn inoculation in a non-blood vessel on the inner side of the wing using a chicken pox thorn seed needle.

Q:What are the dosage requirements for different age groups?

Puncture 1 needle for 20-30 day old chicks and 2 needles for chickens over 30 days old. Young chicks aged 6-20 days require 1 needle with 1-time dilution.

Q:How long can the diluted vaccine be stored?

After dilution, the vaccine must be stored in a cool, dark place and used up within 4 hours.

Q:What should be done if there is no response at the inoculation site?

Check chickens one by one 7 days after inoculation. If there is no response, the inoculation should be supplemented again.